Rodríguez-Hernández H, Cervantes-Huerta M, Rodríguez-Moran M, Guerrero-Romero F

Idioma: Ingles.
Referencias bibliográficas: 24
Paginas: 486-492
Archivo PDF: 76.59 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Ruhl CE, Everhart JE. Trunk fat is associated with increased serum levels of alanine aminotransferase in the United States. Gastroenterology 2010; 138: 1346-56.

2. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98: 960-7.

3. Marchesini G, Avagnina S, Barantani EG, Ciccarone AM, Corica F, Dall’Aglio E, et al Aminotransferase and γ-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J Endocrinol Invest 2005; 28: 333-9.

4. Promrat K, Lutchman G, Uwaifo GI, Freedman RJ, Soza A, Heller T, et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 2004; 39(1): 188-96.

5. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, et al. Prevalence of risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132: 112-7.

6. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-95.

7. Adams LA, Feldstein AE. Nonalcoholic steatohepatitis: risk factors and diagnosis. Expert Rev Gastroenterol Hepatol 2010; 4(5): 623-35.

8. Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, et al. A low-carbohydrate as compared with low-fat diet in severe obesity. N Engl J Med 2003; 348: 2074-81.

9. Stern L, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, et al. The effects of low-carbohydrate versus conventional weight loss diet in severely obese adults: one-year follow-up of a randomized trial. Ann Intern Med 2004; 140: 778-85.

10. Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 1990; 99: 1408-13.

11. Huang MA, Greenson JK, Chao C, Anderson L, Peterman D, Jacobson J, et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 2005; 100: 1072-81.

12. Ryan MC, Abbasi F, Lamendola C, Carter S, McLaughlin TL. Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin resistance adults. Diab Care 2007; 30: 1075-80.

13. American Gastroenterological Association. Medical position statement: nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1702-4.

14. Rodriguez-Hernandez H, Morales-Amaya U, Rosales- Valdez R, Rivera-Hinojosa F, Rodriguez-Moran M, Guerrero- Romero F. Adding cognitive behavioural treatment to either low-carbohydrate or low-fat diet: different short-term effects. Br J Nutr 2009; 102: 1847-53.

15. Prati D, Taoli E, Zanella A, Della Torre E, Butelli S, Del Vechio E, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137: 1-10.

16. Rodriguez-Hernandez H, Cervantes-Huerta M, Gonzalez JL, Marquez-Ramirez MD, Rodriguez-Moran M, Guerrero- Romero F. Nonalcoholic fatty liver disease in asymptomatic obese women. Ann Hepatol 2010; 9: 144-9.

17. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.

18. Marchesini G, Moscatiello S, Di Domizio S, Forlani G. Obesity- associated liver disease. J Clin Endocrinol Metab 2008; 93: S74-S80.

19. Thomas EL, Hamilton G, Patel N, O’Dwyer R, Dore CJ, Goldin RD, et al. Hepatic triglyceride content and its relation to body adiposity: a management resonance imaging and proton magnetic resonance spectroscopy study. Gut 2008; 54: 122-7.

20. Wong VWS, Wong GLH, Choi PC, Chan AWH, Li MKP, Chan HY, et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 2010; 59: 969-74.

21. Foster GD, Wyatt HR, Hill JO, Makris AP, Rosenbaum DL, Brill C, et al. Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet. Ann Intern Med 2010; 153: 147-57.

22. Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 2003; 348: 2082-90.

23. Foster GD, Wyatt HR, Hill JO, Makris AP, Rosenbaum DL, Brill C, et al. Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet. Ann Intern Med 2010; 153: 147-57.

24. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, et al. Liver fibrosis in overweight patients. Gastroenterology 2000; 118: 1117-23.